Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

This article was originally published in The Gray Sheet

Executive Summary

A new law makes vast changes to how clinical laboratory tests will be reimbursed by Medicare over the long term. Although the changes ultimately may lead to payment reductions, both test kits makers and laboratories applaud the new provisions. Reimbursement will better reflect the value that lab tests bring to the health care system, they say.


Related Content

Medtech Supporter Sen. Orrin Hatch To Retire At Year's End
Lab Sector Vs. CMS Battle Heats Up As Medicare Agency Moves Forward With 2018 Rates
Lab Industry Says PAMA Reimbursement Rates Not Really Market-Based
CMS Administrator Seema Verma: What Industry Can Expect
Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp
CMS Takes Steps To Implement New Dx Payment System
New CMS Lab Test Panel Meets To Make Payment Policy Recommendations
Medicare Fee Schedule Blanks On Next-Gen Sequencing
CMS Lessens Lab Test Cuts, Finalizes Revaluation Proposal In Physician Fee Schedule
AdvaMedDx Steps Into Public Sphere: Director Details Diagnostics Priorities





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts